Inspire Investing’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33K Sell
7
-30
-81% -$4.45K ﹤0.01% 1169
2026
Q1
$3.45K Buy
37
+30
+429% +$2.66K ﹤0.01% 988
2025
Q4
$562 Buy
+7
New +$586 ﹤0.01% 1045
2024
Q3
Sell
-14,479
Closed -$2.06M 830
2024
Q2
$2.06M Buy
14,479
+2,942
+26% +$339K 0.24% 106
2024
Q1
$1.29M Sell
11,537
-3,982
-26% -$474K 0.13% 185
2023
Q4
$2.01M Buy
+15,519
New +$2.14M 0.22% 108
2023
Q3
Sell
-1,706
Closed -$313K 793
2023
Q2
$313K Sell
1,706
-341
-17% -$49.1K 0.04% 703
2023
Q1
$273K Sell
2,047
-8,013
-80% -$941K 0.03% 635
2022
Q4
$798K Buy
10,060
+6,667
+196% +$470K 0.1% 176
2022
Q3
$205K Buy
+3,393
New +$219K 0.03% 688

Other funds holding ACLS

Inspire Investing's ACLS Position: Q2 2026 in Review

Inspire Investing reduced its Axcelis (ACLS) stake by 81% in Q2 2026, selling an estimated $4.45K and leaving 7 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1169.

Inspire Investing first reported a position in ACLS in Q3 2022 and has held it in 10 quarters since. The position peaked at $2.06M in Q2 2024. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Inspire Investing held 7 shares of Axcelis worth $1.33K as of Q2 2026.
  • Inspire Investing sold 30 Axcelis shares in Q2 2026, an estimated $4.45K.
  • Axcelis made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1169 holding.
  • Inspire Investing first reported a position in Axcelis in Q3 2022 and has held it in 10 quarters since.
  • Inspire Investing's Axcelis position peaked at $2.06M in Q2 2024.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.